2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).
Publication
, Journal Article
Lyon, AR; López-Fernández, T; Couch, LS; Asteggiano, R; Aznar, MC; Bergler-Klein, J; Boriani, G; Cardinale, D; Cordoba, R; Cosyns, B; Dent, SF ...
Published in: Eur Heart J Cardiovasc Imaging
September 10, 2022
Duke Scholars
Published In
Eur Heart J Cardiovasc Imaging
DOI
EISSN
2047-2412
Publication Date
September 10, 2022
Volume
23
Issue
10
Start / End Page
e333 / e465
Location
England
Related Subject Headings
- Radiation Oncology
- Neoplasms
- Humans
- Hematology
- Heart
- Cardiotoxicity
- Antineoplastic Agents
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., … ESC Scientific Document Group. (2022). 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging, 23(10), e333–e465. https://doi.org/10.1093/ehjci/jeac106
Lyon, Alexander R., Teresa López-Fernández, Liam S. Couch, Riccardo Asteggiano, Marianne C. Aznar, Jutta Bergler-Klein, Giuseppe Boriani, et al. “2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).” Eur Heart J Cardiovasc Imaging 23, no. 10 (September 10, 2022): e333–465. https://doi.org/10.1093/ehjci/jeac106.
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):e333–465.
Lyon, Alexander R., et al. “2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).” Eur Heart J Cardiovasc Imaging, vol. 23, no. 10, Sept. 2022, pp. e333–465. Pubmed, doi:10.1093/ehjci/jeac106.
Lyon AR, López-Fernández T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Cordoba R, Cosyns B, Cutter DJ, de Azambuja E, de Boer RA, Dent SF, Farmakis D, Gevaert SA, Gorog DA, Herrmann J, Lenihan D, Moslehi J, Moura B, Salinger SS, Stephens R, Suter TM, Szmit S, Tamargo J, Thavendiranathan P, Tocchetti CG, van der Meer P, van der Pal HJH, ESC Scientific Document Group. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J Cardiovasc Imaging. 2022 Sep 10;23(10):e333–e465.
Published In
Eur Heart J Cardiovasc Imaging
DOI
EISSN
2047-2412
Publication Date
September 10, 2022
Volume
23
Issue
10
Start / End Page
e333 / e465
Location
England
Related Subject Headings
- Radiation Oncology
- Neoplasms
- Humans
- Hematology
- Heart
- Cardiotoxicity
- Antineoplastic Agents